Group 1 - Revvity exceeded fourth-quarter estimates and forecasts for 2026 revenue and profit, driven by strength in its diagnostics business despite ongoing weakness in academic research funding [1][2] - The company anticipates adjusted profit per share for 2026 to be between $5.35 and $5.45, slightly above analysts' estimates of $5.32 [2] - Revvity projects annual sales for 2026 to be between $2.96 billion and $2.99 billion, surpassing the estimated $2.93 billion [2] Group 2 - Revvity's diagnostics unit achieved 7% organic growth, generating revenue of $390.1 million, significantly exceeding the $377.7 million forecasted by analysts [3] - The life sciences unit reported revenue of $382 million, slightly below the estimated $385.6 million [4] - Quarterly adjusted profit was $1.70 per share, surpassing the expected $1.55 per share, with total quarterly sales reaching $772.1 million, exceeding estimates of $761.3 million [4]

Core Insights - Walt Disney Co. missed expectations on net profit but exceeded slightly on adjusted earnings per share and revenue [1] Financial Performance - The company reported adjusted earnings per share that were slightly ahead of expectations [1] - Revenue figures also came in slightly above forecasts [1]

Core Viewpoint - Twist Bioscience Corporation announced its financial results and business highlights for the first quarter of fiscal 2026, which ended on December 31, 2025 [1]. Financial Results - The detailed fiscal first quarter 2026 earnings report and investor presentation are available on the company's Investor Relations page [2]. Conference Call - The company will hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss financial results and provide business updates [3]. Company Overview - Twist Bioscience focuses on serving customers in various fields such as medicine, agriculture, industrial chemicals, and defense, utilizing synthetic DNA tools to improve lives and sustainability [4]. Technology Platform - The company offers an innovative silicon-based DNA Synthesis Platform that provides precision at an unprecedented scale, enabling cost-effective and rapid synthesis, sequencing, and therapeutics discovery [5].

Group 1 - The IRS is intensifying its scrutiny on side income, with approximately 27% of American workers engaged in side hustles by 2025, although the median income from these gigs is only $200 per month [1] - The modernization of the IRS, funded by the Inflation Reduction Act of 2022, has enabled the agency to utilize advanced data analytics and AI tools for tracking income [2] - The IRS defines "gig work" broadly, encompassing earnings from ride-sharing, property rentals, online sales, errands, and freelance services [3] Group 2 - Any side income exceeding $400 annually must be reported to the IRS, which has various methods to track unreported income [3][4] - Third-party vendors and corporations are required to report payments made for gig work, with companies like Airbnb and Uber confirming this obligation [4] - Banking institutions report direct payments to accounts, while peer-to-peer payment processors like Venmo and PayPal must report accounts with over 200 transactions and $20,000 in net transaction value within a tax year [5]

ServiceNow, Inc. ( NOW ) looks like a clear buy; the market is fundamentally misreading the "SaaS disruption" narrative by lumping ServiceNow with legacy software providers. The truth is that ServiceNow isn't just another app collection; I view it as the underlyingA curious investing mind focused on strong-moat companies across various industries. Admirer of Buffett and Munger's investing style. Long term horizon. I am also a Contributor in Yahoo Finance Community (beta stage). Featured contributor on Yahoo ...

Core Viewpoint - ServiceNow, Inc. (NOW) is positioned as a strong investment opportunity, as the market is misinterpreting its role in the SaaS disruption narrative by associating it with legacy software providers [1] Company Analysis - ServiceNow is not merely a collection of applications; it is viewed as a foundational platform that offers significant competitive advantages [1] - The company is recognized for its strong moat, which is essential for long-term investment strategies [1] Investment Philosophy - The investment approach emphasizes a long-term horizon, focusing on price and margin of safety while considering risks often overlooked by short-term analysts [1]

Core Insights - Giverny Capital Asset Management's portfolio returned 0.01% in Q4 2025, underperforming the S&P 500's 2.66% return, and YTD returns were 12.58% compared to the Index's 17.88% [1] - The firm faced challenges due to underweighting in large technology companies and overweighting in smaller niche leaders, despite strong earnings growth and capital returns from portfolio companies [1] - The market's focus on AI investments has overshadowed the actual benefits of portfolio companies, impacting overall performance [1] Company Performance - Arista Networks, Inc. (NYSE:ANET) was highlighted as a leading contributor to Giverny Capital's performance, with a one-month return of 3.32% and a 52-week gain of 27.12% [2] - As of January 30, 2026, Arista Networks' stock closed at $141.74, with a market capitalization of $178.491 billion [2] - Arista Networks has been the best-performing stock for Giverny Capital since inception, providing high-quality routers and switches for major clients like Meta Platforms and Microsoft [3] Market Sentiment - Despite strong revenue growth of 27.5% year-over-year to $2.3 billion in Q3 2025, Arista Networks is not among the top 30 most popular stocks among hedge funds, with 92 hedge fund portfolios holding the stock at the end of Q3 [4] - There is a belief that certain AI stocks may offer greater upside potential and less downside risk compared to Arista Networks, despite its strong fundamentals [4]

Core Insights - Inflation significantly impacts retirees by reducing their purchasing power over time, especially as their income sources are often fixed or limited [1][3] - Retirees face unique challenges in managing inflation, as they cannot easily increase their income like working individuals can [2][3] Inflation Impact on Retirees - Inflation erodes the value of static income sources such as pensions and certificates of deposit (CDs), which may not keep pace with rising costs [3] - Rising healthcare and insurance premiums further exacerbate the financial strain on retirees, necessitating proactive planning for increased expenses [3] Planning for Inflation - Financial experts recommend preparing for a 3% inflation rate for general expenses and a 7% rate for healthcare costs, reflecting historical trends [4] - Stress-testing retirement plans against higher inflation rates is essential to ensure retirees can maintain their lifestyle [4] Investment Strategies - Maintaining some exposure to stocks is advised, as they have historically provided higher long-term returns than inflation, helping to preserve purchasing power [6] - Inflation-linked bonds, such as Treasury Inflation-Protected Securities (TIPS) and I Bonds, are recommended as reliable tools for keeping pace with rising prices [7]

Under the agreement, CFFM will purchase Pulsenmore ES home ultrasound services, enabling patients to benefit from remote monitoring while reducing unnecessary visits to the diagnostic center. Pulsenmore redefines prenatal care through clinically validated home ultrasound and telehealth technology, addressing one of the fastest-growing needs in global healthcare: high-quality care delivered beyond the clinic. Positioned at the intersection of digital health, telemedicine, and femtech, Pulsenmore enables rem ...

MIRAMAR, Fla.--(BUSINESS WIRE)--VSE Corporation ("VSE†or the "Company†) (NASDAQ: VSEC), a leading provider of aviation aftermarket distribution and repair services, announced today that it has commenced concurrent underwritten public offerings, subject to market and other conditions, of $650 million of its common stock and tangible equity units (the "Units†) with an aggregate stated amount of $350 million, pursuant to an effective shelf registration statement. In addition, VSE intends to grant the under ...